“Triple Threat-Triple Benefit: The Rise of GLP1-GCG-FGF21 Tritagonists in Tomorrow’s Metabolic Medicine ” (2025) Diabzen, 3(3), pp. 43–48. Available at: https://thediabzen.com/index.php/d/article/view/19 (Accessed: 14 April 2026).